RKDA vs. LOCL, ORIS, NCRA, SANW, SISI, IVP, SEED, CEAD, EDBL, and AAGR
Should you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Local Bounti (LOCL), Oriental Rise Holdings Limited Ordinary Shares (ORIS), Nocera (NCRA), S&W Seed (SANW), Shineco (SISI), Inspire Veterinary Partners (IVP), Origin Agritech (SEED), CEA Industries (CEAD), Edible Garden (EDBL), and African Agriculture (AAGR). These companies are all part of the "agriculture" industry.
Arcadia Biosciences vs.
Local Bounti (NYSE:LOCL) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking.
Arcadia Biosciences received 280 more outperform votes than Local Bounti when rated by MarketBeat users. Likewise, 53.06% of users gave Arcadia Biosciences an outperform vote while only 31.58% of users gave Local Bounti an outperform vote.
Arcadia Biosciences has a consensus price target of $6.00, indicating a potential upside of 21.21%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Arcadia Biosciences is more favorable than Local Bounti.
Local Bounti has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500.
28.0% of Local Bounti shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 31.5% of Local Bounti shares are owned by company insiders. Comparatively, 1.8% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Arcadia Biosciences has a net margin of -110.61% compared to Local Bounti's net margin of -427.08%. Arcadia Biosciences' return on equity of -52.63% beat Local Bounti's return on equity.
Arcadia Biosciences has lower revenue, but higher earnings than Local Bounti. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Local Bounti, indicating that it is currently the more affordable of the two stocks.
In the previous week, Local Bounti and Local Bounti both had 1 articles in the media. Arcadia Biosciences' average media sentiment score of 1.87 beat Local Bounti's score of 0.00 indicating that Arcadia Biosciences is being referred to more favorably in the news media.
Summary
Arcadia Biosciences beats Local Bounti on 12 of the 17 factors compared between the two stocks.
Get Arcadia Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Arcadia Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:RKDA) was last updated on 6/11/2025 by MarketBeat.com Staff